ArticleEuropean heart journal. Case reports2025
Pickering syndrome facilitated by seronegative immune mediated necrotizing myopathy: a case report.
Article in European heart journal. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Seronegative Immune-Mediated Necrotizing Myopathy: An Overview for Optimal Clinical Management.Current rheumatology reports · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Immune-mediated necrotizing myopathies (IMNM) are rare types of idiopathic inflammatory myopathies characterized by severe proximal muscle weakness and muscle fibre necrosis with a paucity of inflammatory cells. Serologically, IMNM are further classified into three subtypes based on the presence or absence of two specific autoantibodies: the anti-3-hydroxy-3-methylglutaryl coenzyme A reductase and the anti-signal recognition particle. Especially the seronegative form exhibits a higher risk of various extra skeletal muscle involvement, including cardio-myositis. Nevertheless, severe cardiac involvement remains an extremely rare yet potentially life-threatening clinical manifestation of seronegative IMNM. Case summary: A 59-year-old male previously diagnosed with seronegative IMNM presented with severe hypertension and acute cardiac decompensation. On echocardiography, cardiac function was reduced with signs of eccentric left ventricular hypertrophy. Coronary angiography was normal, but cardiac magnetic resonance (CMR) found diffuse intra-myocardial oedema. The patient was suspected of having IMNM associated cardio-myositis and was started on heart failure therapy. In parallel, his immunosuppressive treatment was increased. Under this regiment, the patient rapidly developed acute renal failure caused by bilateral renal artery stenosis. After successful stenting of the stenotic arteries, cardiac and renal function significantly improved, and at 1-year follow-up, no more signs of myocardial oedema or inflammation were found on CMR. Discussion: Here, we describe a new case of acute congestive heart failure facilitated by severe reno-vascular hypertension in a patient with seronegative IMNM. This case highlights the importance of early recognition and treatment of hypertension in IMNM patients to avoid major adverse cardiac events.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.